Group 1: Investor Relations Activities - The report includes various investor relations activities such as analyst meetings, performance briefings, and roadshows [2][3] - Specific participants from different asset management companies and investment firms were involved in the activities [2][3] Group 2: Impact of COVID-19 - The COVID-19 pandemic has negatively affected the company's operations, particularly due to school closures and lockdowns in Shanghai [3][4] - The company has implemented measures to mitigate the impact, including maintaining production and logistics operations during lockdowns [3][4] Group 3: Research Funding and Growth - Research funding in China is expected to maintain stable growth, with an average annual compound growth rate of 11.69% from 2012 to 2021 [3][4] - The company plans to continue investing in research and development, particularly in self-owned brands and products [4] Group 4: Financial Performance - In 2021, the company's revenue from self-owned brands "Absin" and "LabEx" reached 51.16 million yuan, a year-on-year increase of 124.26% [4] - The company's gross margin was 23% in 2021, with plans to improve it through enhanced product offerings and market share [4]
优宁维(301166) - 优宁维调研活动信息